S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AKBA Akebia Therapeutics Inc

1.4099

0.1099 (8.45%)

Last Updated: 11:50:29

Delayed by 15 minutes

NRx Pharma, Cassava Sciences lead weekly healthcare gainers; Seres Therapeutics trail

To read the full story on Seeking Alpha, click here.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics Inc News

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights
Thursday 2 May 2024 (1 day ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 1 May 2024 (2 days ago) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 2 April 2024 (1 month ago) • PR Newswire (US)

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Wednesday 27 March 2024 (1 month ago) • PR Newswire (US)

Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Thursday 14 March 2024 (2 months ago) • PR Newswire (US)

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Monday 11 March 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 1 March 2024 (2 months ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

More Akebia Therapeutics Inc News Articles

RespireRx Pharmaceuticals (PK)

Global Developments (PK)

Voip Pal Com (QB)

MicroCloud Hologram

Brookmount Explorations (PK)

Globestar Therapeutics (PK)

Bell Buckle (PK)

NaturalShrimp (QB)

Moon Equity (PK)

BlackStar Enterprise (PK)

Yuenglings Ice Cream (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions